154 related articles for article (PubMed ID: 28798990)
1. Myocardial
Liga R; Gimelli A; Marzullo P; Ambrosio G; Cameli M; Cerbai E; Coiro S; Emdin M; Marcucci R; Morrone D; Palazzuoli A; Petronio AS; Savino K; Padeletti L; Pedrinelli R;
J Nucl Cardiol; 2018 Apr; 25(2):461-470. PubMed ID: 28798990
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging.
Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Ida K; Sugihara H; Takeda K; Nakagawa M
Eur J Nucl Med; 1996 Jul; 23(7):756-61. PubMed ID: 8662113
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
Kuwahara T; Hamada M; Hiwada K
J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
[TBL] [Abstract][Full Text] [Related]
4. Neuronal dysfunction in heart failure assessed by cardiac 123-iodine metaiodobenzylguanidine scintigraphy.
Somsen GA; van der Wall EE; van Vlies B; Borm JJ; van Royen EA
Int J Card Imaging; 1996 Dec; 12(4):305-10. PubMed ID: 8993993
[TBL] [Abstract][Full Text] [Related]
5. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.
Giordano A; Melina G; Calcagni ML; Schinzari F; Cirillo F; Mettimano M; Cardillo C; Melina D
Arch Med Res; 2007 Jul; 38(5):512-8. PubMed ID: 17560456
[TBL] [Abstract][Full Text] [Related]
6. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of cardiac sympathetic imaging in heart failure.
Christensen TE; Kjaer A; Hasbak P
Clin Physiol Funct Imaging; 2014 May; 34(3):178-82. PubMed ID: 24138454
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M
J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194
[TBL] [Abstract][Full Text] [Related]
9. Regional Cardiac Sympathetic Nervous System Evaluation Using 123I-mIBG SPECT in Patients with Heart Failure.
Iqbal B; Currie G; Kiat H
J Med Imaging Radiat Sci; 2018 Dec; 49(4):397-405. PubMed ID: 30514557
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-metaiodobenzylguanidine scintigraphy in risk stratification of sudden death in heart failure.
Martins da Silva MI; Vidigal Ferreira MJ; MorĂ£o Moreira AP
Rev Port Cardiol; 2013 Jun; 32(6):509-16. PubMed ID: 23731734
[TBL] [Abstract][Full Text] [Related]
11. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease.
Mitrani RD; Klein LS; Miles WM; Hackett FK; Burt RW; Wellman HN; Zipes DP
J Am Coll Cardiol; 1993 Nov; 22(5):1344-53. PubMed ID: 8227790
[TBL] [Abstract][Full Text] [Related]
12. Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
Ohya Y; Sasaki M; Fujishima S; Kagiyama S; Onaka U; Kaseda S; Ohmori S; Kuwabara Y; Abe I; Fujishima M
Clin Exp Hypertens; 2001 May; 23(4):293-304. PubMed ID: 11349821
[TBL] [Abstract][Full Text] [Related]
13. Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure.
Rabinovitch MA; Rose CP; Rouleau JL; Chartrand C; Wieland DM; Lepanto L; Legault F; Suissa S; Rosenthall L; Burgess JH
Circ Res; 1987 Dec; 61(6):797-804. PubMed ID: 2960468
[TBL] [Abstract][Full Text] [Related]
14. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.
Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M
Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension.
Watanabe K; Sekiya M; Tsuruoka T; Funada J; Kameoka H; Miyagawa M; Kohara K
J Hypertens; 1999 Aug; 17(8):1161-8. PubMed ID: 10466472
[TBL] [Abstract][Full Text] [Related]
16. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload.
Morimitsu T; Miyahara Y; Sinboku H; Ikeda S; Naito T; Nishijima K; Takao M
J Nucl Med; 1996 Aug; 37(8):1343-6. PubMed ID: 8708768
[TBL] [Abstract][Full Text] [Related]
17. Assessment of therapeutic effects of statin on cardiac sympathetic nerve activity and cardiac events in patients with ischemic cardiomyopathy and mild to moderate heart failure.
Kasama S; Toyama T; Suzuki S; Ito Y; Matsumoto N; Kurabayashi M; Kasahara M
Nucl Med Commun; 2019 Feb; 40(2):159-168. PubMed ID: 30461696
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Cardiac Sympathetic Nerve Imaging Using (123)Iodine-Metaiodobenzylguanidine Scintigraphy for Predicting Sudden Cardiac Death in Patients With Heart Failure.
Kasama S; Toyama T; Kurabayashi M
Int Heart J; 2016; 57(2):140-4. PubMed ID: 26973278
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]